In what has been dubbed by Australia’s Prime Minister as the “year of innovation”, AusBiotech calls on leaders of biotechnology companies (CEOs and MDs) to respond to the annual CEO Biotechnology Industry Position Survey 2016 as matter of importance.
The survey takes the annual snapshot of the industry to build the advocacy platform for the year to come – and will have added significance this year, with a pending Federal election, a review of the R&D Tax Incentive and the Government’s focus on innovation as it rolls out its National Innovation and Science Agenda.
AusBiotech conducts the confidential Survey early each year to formally seek opinions and information from the leaders of the industry it represents, to get a comprehensive view of the Australian biotechnology sector based on industry experience, knowledge, key metrics and political insight.
While input on public policy is a year-round, on-going and core part of AusBiotech’s work, the Survey informs efforts and the industry’s contribution and support makes those efforts far more powerful.
The results help build metrics about the significance of the industry and its perspectives and help AusBiotech to make strong statements about the magnitude of issues, trends and company practices.
The collated results appear in a printed report that is widely used as a source of industry views and information, as well as giving valuable ballast to AusBiotech’s advocacy efforts.
Again this year AusBiotech and survey sponsor Grant Thornton will be conducting facilitated focus groups for CEOs, MDs or their C-suite delegate in April, to discuss the ‘Government Policy’ section of the survey in more detail.
The Survey has been posted and emailed to biotechnology company leaders and responses are invited now.
If you have any questions about the Survey, who it’s been sent to in your office, or the focus groups, please contact Lorraine Chiroiu (AusBiotech’s Chief Industry Affairs Officer) at lchiroiu@ausbiotech.org or 03 9828 1400.